PI3K/AKT/mTOR 信号通路在乳腺癌HER2治疗耐药中的作用研究进展

doi:10.11904/j.issn.1002-3070.2014.04.015

Abstract

Abstract: Abstract HER2-targeting therapy is an important part of the treatment for breast cancer with HER2 overexpression. However, the therapy effectiveness is largely influenced by HER2 resistance. Previous studies have confirmed that PI3K/AKT/mTOR signaling pathway is activated during the process of drug resistance to HER2-targeting therapy. Therefore, investigating the PI3K/AKT/mTOR signaling pathway and drugs-targeted pathway is important for the treatment of breast cancer.

Key words: PI3K/AKT/mTOR pathway, HER2 , Breast neoplasms, Targeted therapy

CLC Number:

R730.231

MA RuiJin,YANG Yu. The research development of PI3K/AKT/mTOR signaling pathway in HER2 resistance for the treatment of breast cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2014, 28(4): 360-363.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2014.04.015

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2014/V28/I4/360

[1]	SHAO Yuming, ZHU Kunbing, ZHANG Jie. Research progress of SP/NK-1R system in breast cancer [J]. Journal of Practical Oncology, 2024, 38(4): 268-272.
[2]	Breast Oncology Group of Heilongjiang Medical Association. Expert consensus on clinicopathological diagnosis of breast cancer with low expression of HER2 in Heilongjiang province(2024 edition) [J]. Journal of Practical Oncology, 2024, 38(2): 71-78.
[3]	FAN Tingting, DING Danni, ZHAO Zixue, YU Yang, HAN Fengjuan. Fatty acid metabolism and ovarian cancer [J]. Journal of Practical Oncology, 2023, 37(5): 429-433.
[4]	LUN Lixin, ZHONG Zhenbin, ZHAO Xinyu, WU Chou, HAO Chuncheng. Research progress of anti-EGFR therapy in head and neck squamous cell carcinoma [J]. Journal of Practical Oncology, 2023, 37(3): 276-280.
[5]	FENG Chengtian, HUANG Furong, JIANG Yongdong. Research progress of lipid metabolism on the mechanism of drug resistance to trastuzumab therapy in breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 155-159.
[6]	WANG Jiabei, ZHANG Yunguang, LIU Lianxin. Clinical efficacy and safety analysis of immunotherapy combined with molecularly targeted drugs in the treatment of advanced hepatocellular carcinoma:A single-arm retrospective study [J]. Journal of Practical Oncology, 2022, 36(6): 489-494.
[7]	WU Ruiyue, ZHU Kaili, YANG Jingru, LING Xiaoling. Clinical research progress of breast cancer with low HER2 expression [J]. Journal of Practical Oncology, 2022, 36(6): 570-575.
[8]	WANG Xinghan, LV Yalei. Mechanisms of trastuzumab resistance and post-resistance treatment strategies in HER2-positive breast cancer [J]. Journal of Practical Oncology, 2022, 36(5): 445-451.
[9]	LI Zhihui, LI Zhigao. Research progress of T-DM1 in treatment of HER2 positive breast cancer [J]. Journal of Practical Oncology, 2022, 36(5): 477-482.
[10]	ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488.
[11]	ZHENG Yanli, HE Jianxia. Research progress of DNA methylation in diffuse large B-cell lymphoma [J]. Journal of Practical Oncology, 2022, 36(3): 259-262.
[12]	CHEN Su, SUI Hong. Research progress of anti-HER2 therapy in metastatic colorectal cancer [J]. Journal of Practical Oncology, 2022, 36(3): 288-292.
[13]	WU Fangfang, ZHENG Tongsen. Research status and prospect of adjuvant therapy for biliary tract malignant tumors [J]. Journal of Practical Oncology, 2022, 36(2): 156-161.
[14]	HOU Jianxun, WANG Hongbin. Research progress on the influence of exosomes in the integration of breast cancer diagnosis and treatment [J]. Journal of Practical Oncology, 2022, 36(2): 178-182.
[15]	MA Buhuan¹, LIU Caixia². Research progress of Jagged1 promoting the occurrence,development and distant metastasis of breast cancer [J]. Journal of Practical Oncology, 2021, 35(5): 452-457.

The research development of PI3K/AKT/mTOR signaling pathway in HER2 resistance for the treatment of breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments